Close Menu

A PLOS One study by Norwegian researchers suggests metabolomic markers in blood and urine samples from pregnant women can help in predicting preeclampsia risk. Using a magnetic resonance-based metabolomics profiling approach, the team tested blood and urine samples from 10 pregnant women with preeclampsia, 10 unaffected pregnancies, and 10 age-matched women who were not pregnant.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.